FeaturesSignalPricingFounders
Log inGet started free
UV

UCB Ventures

Venture CapitalQuiet

UCB Ventures is a вВђ150 million strategic corporate venture fund

Brussels, BelgiumFounded 2020ucbventures.com/
4
Investments
0
Exits
—
AUM
0.0%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for UCB Ventures.

Get started free

Investment Thesis & Strategy

UCB Ventures, as a strategic corporate venture fund, invests across various stages in the general industry, seeking to support innovative companies that align with UCB's strategic goals.

Investment Activity

Deals per year over the last 10 years

1
2013
0
2014
0
2015
1
2016
0
2017
2
2018
0
2019
0
2020
3
2021
3
2022

Portfolio Companies

Selected investments from their portfolio of 4 companies

R
Rgenta Therapeutics
Biotech · Series A, 2022
Active
O
Obsidio
Biotech · Series A, 2022
Active
A
Acelyrin
Biotech · Series B, 2022
Active
T
Tessera Therapeutics
Biotech · Series B, 2021
Active
E
Enthera Pharmaceuticals
Biotech · Series A, 2021
Active
A
Alentis Therapeutics
Biotech · Series A, 2021
Active
C
Cortexyme
Biotech · Series B, 2018
Active
I
Inari
Biotech · Series B, 2018
Active
C
Cerevance
Biotech · Series A, 2016
Active
A
Apellis Pharmaceuticals
Biotech · Series A, 2013
Active

Frequently Asked Questions

UCB Ventures focuses on Series A, Series B, Series C+ stage investments.

Related Investors

PMV

Brussels, Belgium · 65 deals

Inventures SA

Brussels, Belgium · 37 deals

European regional development fund (ERDF)

Brussels, Belgium · 34 deals

Verlinvest

Brussels, Belgium · 31 deals

SFPI-FPIM

Brussels, Belgium · 26 deals

SmartFin

Brussels, Belgium · 24 deals